RELAPSING FORMS OF MULTIPLE SCLEROSIS
Clinical trials for RELAPSING FORMS OF MULTIPLE SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new RELAPSING FORMS OF MULTIPLE SCLEROSIS trials appear
Sign up with your email to follow new studies for RELAPSING FORMS OF MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New MS drug safety checked in asian patients
Disease control CompletedThis study tested the safety and how the body processes the drug diroximel fumarate in adults with relapsing forms of multiple sclerosis (MS) from the Asia-Pacific region. It involved 136 participants who took the drug for either 24 or 48 weeks. The main goal was to see how well …
Matched conditions: RELAPSING FORMS OF MULTIPLE SCLEROSIS
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
MS drug trial halted after initial safety check
Disease control CompletedThis study tested a new drug, BIIB091, for people with relapsing forms of multiple sclerosis (MS). In Part 1, researchers compared BIIB091 taken alone to an existing MS drug (diroximel fumarate) to check safety and see its effect on brain inflammation seen on MRI scans. Based on …
Matched conditions: RELAPSING FORMS OF MULTIPLE SCLEROSIS
Phase: PHASE2 • Sponsor: Biogen • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Spanish study checks if MS drug works as promised in real life
Disease control CompletedThis study looked at how well the multiple sclerosis drug ofatumumab (brand name Kesimpta) worked for 310 patients in regular Spanish clinics. It aimed to see if the drug effectively reduced relapses and was safe when used outside of controlled trials. Researchers collected infor…
Matched conditions: RELAPSING FORMS OF MULTIPLE SCLEROSIS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC